Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 10/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11696381 | 1.00 | FAAH (0.55) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL9946939 | 1.00 | FAAH (0.55) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL12753930 | 0.92 | GAA (0.61) | GAAALDH1A1LMNACYP2C9CYP1A2 | |
| SCHEMBL1876276 | 0.92 | GAA (0.61) | GAAALDH1A1LMNACYP2C9CYP1A2 | |
| SCHEMBL2451978 | 0.89 | GAA (0.58) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL2451979 | 0.89 | GAA (0.58) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL2451656 | 0.88 | GAA (0.57) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL2451388 | 0.88 | GAA (0.57) | FAAHGAAALDH1A1LMNACYP2C9 | |
| SCHEMBL11693886 | 0.88 | FAAH (0.53) | FAAHGAAALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL2451659 | 0.88 | GAA (0.57) | FAAHGAAALDH1A1LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017168438-A1 | PROCESS FOR PREPARING PURE ALLYL PROTECTED KETO DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2017-10-05 | — | — | WO | disclosed |
| US-20070049748-A1 | PREPARATION OF EZETIMIBE | DR. REDDY'S LABORATORIES, INC. | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049748-A1 | PREPARATION OF EZETIMIBE | PCSK9, EZR, APOB | FAAH 1117/4885GAA 349/4885ALDH1A1 1949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.